<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00541762</url>
  </required_header>
  <id_info>
    <org_study_id>EKBB 86/05</org_study_id>
    <secondary_id>SNF Grant. 3200-065588.04/1</secondary_id>
    <nct_id>NCT00541762</nct_id>
  </id_info>
  <brief_title>Regulation of Fat-stimulated Neurotensin Secretion in Healthy Subjects</brief_title>
  <official_title>Mechanistic Study (Physiology)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Basel, Switzerland</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Basel, Switzerland</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Context: Cholecystokinin (CCK) and neurotensin are stimulated during meal intake by the
      presence of fat in the small intestine. The sequence of events suggests that fat hydrolysis
      is crucial for triggering the release.

      Objectives: The aim of this study was therefore to investigate whether CCK mediated the
      effect of intraduodenal (ID) fat on neurotensin secretion via CCK-1 receptors.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Setting: Single center study; 34 male volunteers were studied in consecutive, randomized,
      double blind, crossover studies.

      Subjects and Methods: CCK and neurotensin release were quantified in: 1) 12 subjects
      receiving an ID fat infusion with or without 60 mg orlistat, an irreversible inhibitor of
      gastrointestinal lipases, in comparison to vehicle. 2) 12 subjects receiving ID long chain
      fatty acids (LCF), ID medium chain fatty acids (MCF) or ID vehicle. 3) 10 subjects receiving
      ID LCF with and without the CCK-1 receptor antagonist dexloxiglumide (DEXLOX) or ID vehicle
      plus IV saline (placebo). Hormone concentrations were measured by specific RIA systems.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2006</start_date>
  <completion_date type="Actual">March 2007</completion_date>
  <primary_completion_date type="Actual">March 2007</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Neurotensin plasma concentrations</measure>
    <time_frame>Change in plasma cocnentrations over 2-3 hours</time_frame>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">34</enrollment>
  <condition>Healthy</condition>
  <arm_group>
    <arm_group_label>A, 3; B, 3; C, 3</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>A, 3: Fat with and without orlistat or placebo. B, 3: LCF vs MCF vs placebo. C, 3: LCF with and without DEXLOX or placebo.</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Fat perfusion to the small intestine</intervention_name>
    <description>Triglycerides, long chain fatty acids, medium chain fatty acids perfused to the small intestine
Orlistat perfused to the small intestine
DEXLOX as CCK-1 receptor antagonist</description>
    <arm_group_label>A, 3; B, 3; C, 3</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Healthy male subjects
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>35 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Juergen Drewe, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, 4031 Basel, Switzerland</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Christoph Beglinger, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Research and Clinical Pharmacology, University Hospital, Basel Switzerland</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Clinical Research Center, University Hospital</name>
      <address>
        <city>Basel</city>
        <zip>CH-4031</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <link>
    <url>http://www.ncbi.nlm.nih.gov/pubmed/18303078</url>
    <description>publication in JCEM</description>
  </link>
  <reference>
    <citation>Ferris CF, Carraway RE, Hammer RA, Leeman SE. Release and degradation of neurotensin during perfusion of rat small intestine with lipid. Regul Pept. 1985 Oct;12(2):101-11.</citation>
    <PMID>3840906</PMID>
  </reference>
  <verification_date>March 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 8, 2007</study_first_submitted>
  <study_first_submitted_qc>October 9, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 10, 2007</study_first_posted>
  <last_update_submitted>March 9, 2015</last_update_submitted>
  <last_update_submitted_qc>March 9, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 10, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Neurotensin</keyword>
  <keyword>Human</keyword>
  <keyword>Physiology of neurotensin</keyword>
  <keyword>fat perfusion</keyword>
  <keyword>healthy subjects</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

